Bristol Myers (BMY) faces a patent cliff, but a robust pipeline and CAR-T optionality plus 4.3% yield could spark upside—see ...

Bristol-Myers Squibb’s first quarter results were notably shaped by ongoing momentum in its growth portfolio and steady ...

Discusses Approval of AUVELITY for Agitation Associated With Dementia Due to Alzheimer's Disease May 1, 2026 8:00 ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

After delaying a late-stage readout last year due to “irregularities” at certain study sites, pivotal data for Bristol Myers ...

By Michael Erman and Puyaan Singh April 30 (Reuters) - Bristol Myers Squibb reported a first-quarter profit that beat Wall ...

Creative: One half of Meta’s Super Bowl campaign, “Hey Meta, Who Eats Art?” followed Chris Hemsworth and Chris Pratt, playing art-curious bros learning about highbrow works, as they inadvertently ...

Forbes contributors publish independent expert analyses and insights. I cover Hollywood and entertainment. The movie business starts sharpening its fang for big business in 2025 in January with Wolf ...

Soccer's Lionel Messi, music artist Bad Bunny and actor Timothée Chalamet are among luminaries who have teamed up for an ...

Refined strategy and disciplined execution position Company to unlock value from its portfolio, which includes Celea Therapeutics’ Phase 3-ready deupirfenidone for idiopathic pulmonary fibrosis, ...

A newly discovered comet, C/2025 R3 (PanSTARRS), could be the brightest of its kind visible from Earth in 2026. The comet will make its closest approach to the sun on April 19 and its closest approach ...